NASDAQ:BCLI
$2.94
(
3.16%
)
Friday, 26th May 2023
Brainstorm Cell Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.60 | $3.29 | Friday, 26th May 2023 BCLI stock ended at $2.94. This is 3.16% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 5.34% from a day low at $2.81 to a day high of $2.96. |
| 90 days | $1.43 | $3.46 | |
| 52 weeks | $1.09 | $4.70 |
Historical Brainstorm Cell Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $2.94 | $2.96 | $2.81 | $2.94 | 42 641 |
| 2023-05-25 | $3.00 | $3.04 | $2.85 | $2.85 | 89 263 |
| 2023-05-24 | $3.01 | $3.10 | $3.00 | $3.06 | 46 807 |
| 2023-05-23 | $3.04 | $3.19 | $2.96 | $3.00 | 162 359 |
| 2023-05-22 | $2.89 | $3.05 | $2.83 | $3.05 | 149 439 |
| 2023-05-19 | $2.78 | $2.92 | $2.72 | $2.85 | 123 037 |
| 2023-05-18 | $2.76 | $2.81 | $2.72 | $2.76 | 61 833 |
| 2023-05-17 | $2.69 | $2.82 | $2.60 | $2.76 | 80 659 |
| 2023-05-16 | $2.70 | $2.74 | $2.62 | $2.70 | 137 741 |
| 2023-05-15 | $2.76 | $2.93 | $2.70 | $2.76 | 223 093 |
| 2023-05-12 | $2.87 | $2.89 | $2.75 | $2.76 | 157 097 |
| 2023-05-11 | $2.97 | $2.97 | $2.85 | $2.86 | 103 909 |
| 2023-05-10 | $2.95 | $2.99 | $2.87 | $2.97 | 83 698 |
| 2023-05-09 | $2.79 | $2.95 | $2.79 | $2.85 | 182 817 |
| 2023-05-08 | $3.05 | $3.11 | $2.86 | $2.94 | 315 610 |
| 2023-05-05 | $3.23 | $3.23 | $2.94 | $2.99 | 210 288 |
| 2023-05-04 | $3.12 | $3.29 | $3.10 | $3.20 | 259 598 |
| 2023-05-03 | $3.00 | $3.20 | $3.00 | $3.08 | 292 373 |
| 2023-05-02 | $2.98 | $3.11 | $2.89 | $3.00 | 210 669 |
| 2023-05-01 | $2.95 | $3.08 | $2.92 | $2.99 | 215 563 |
| 2023-04-28 | $2.89 | $3.06 | $2.83 | $2.89 | 218 650 |
| 2023-04-27 | $2.80 | $2.91 | $2.72 | $2.89 | 120 174 |
| 2023-04-26 | $2.79 | $2.88 | $2.73 | $2.80 | 80 090 |
| 2023-04-25 | $3.00 | $3.15 | $2.67 | $2.78 | 440 422 |
| 2023-04-24 | $3.09 | $3.35 | $2.98 | $3.05 | 578 809 |
| 2023-04-21 | $2.69 | $3.09 | $2.65 | $3.05 | 297 117 |
| 2023-04-20 | $2.61 | $2.82 | $2.58 | $2.69 | 321 651 |
| 2023-04-19 | $2.58 | $2.75 | $2.57 | $2.61 | 224 567 |
| 2023-04-18 | $2.65 | $2.69 | $2.56 | $2.67 | 118 380 |
| 2023-04-17 | $2.84 | $2.86 | $2.50 | $2.61 | 377 455 |
| 2023-04-14 | $2.77 | $2.87 | $2.71 | $2.81 | 262 120 |
| 2023-04-13 | $2.63 | $2.90 | $2.63 | $2.75 | 268 065 |
| 2023-04-12 | $2.80 | $2.81 | $2.59 | $2.63 | 236 253 |
| 2023-04-11 | $2.84 | $3.02 | $2.82 | $2.86 | 271 862 |
| 2023-04-10 | $2.74 | $2.93 | $2.69 | $2.85 | 211 631 |
| 2023-04-06 | $2.82 | $2.85 | $2.62 | $2.81 | 189 296 |
| 2023-04-05 | $2.56 | $3.10 | $2.55 | $2.82 | 1 971 795 |
| 2023-04-04 | $2.99 | $3.08 | $2.40 | $2.67 | 1 294 276 |
| 2023-04-03 | $3.30 | $3.43 | $2.91 | $2.99 | 931 709 |
| 2023-03-31 | $2.57 | $3.46 | $2.57 | $3.30 | 2 841 821 |
| 2023-03-30 | $2.42 | $2.60 | $2.03 | $2.50 | 679 958 |
| 2023-03-29 | $1.81 | $2.47 | $1.81 | $2.44 | 1 776 667 |
| 2023-03-28 | $1.72 | $1.87 | $1.62 | $1.84 | 583 408 |
| 2023-03-27 | $1.80 | $1.92 | $1.56 | $1.60 | 2 908 727 |
| 2023-03-24 | $1.51 | $1.60 | $1.51 | $1.55 | 81 291 |
| 2023-03-23 | $1.64 | $1.64 | $1.54 | $1.59 | 80 960 |
| 2023-03-22 | $1.62 | $1.63 | $1.53 | $1.55 | 50 531 |
| 2023-03-21 | $1.57 | $1.63 | $1.54 | $1.63 | 63 790 |
| 2023-03-20 | $1.66 | $1.66 | $1.54 | $1.60 | 156 281 |
| 2023-03-17 | $1.55 | $1.63 | $1.51 | $1.61 | 142 096 |
About Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
